• Fujifilm Holdings America Corporation launched the EB-710US endobronchial ultrasound bronchoscope for the US market, targeting faster pulmonary procedure throughput and lower per-case consumable spend.
• The balloon-less approach aims to reduce reprocessing-related infection risk exposure, a potential differentiator for hospitals tightening quality metrics and cost controls.
• The product positions Fujifilm to compete more aggressively in EBUS by pairing workflow simplification with imaging performance claims, supporting broader adoption across pulmonology service lines.
• Fujifilm is showcasing the device at the American Thoracic Society Conference running May 18-20 in Orlando, signaling a push to accelerate clinical trial and purchasing conversations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fujifilm Holdings America Corporation published the original content used to generate this news brief on May 18, 2026, and is solely responsible for the information contained therein.